It could be plausible that there are other underlying factors (such as hormonal status, the level of adipokine-like Adiponectin, and functionality of adipose tissue in early obesity vs. obesity at later stages) that influence the breast tumor progression. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.